Article
Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma
3 Sept 2024
Abstract excerpt
BACKGROUND: Risk of early-stage lung adenocarcinoma recurrence after surgical resection is significant, and the postrecurrence median survival is approximately 2 years. Currently, there are no commercially available biomarkers that predict recurrence. In this study, we investigated whether microbial and host genomic signatures in the lung can predict recurrence. METHODS: In 91 patients with early-stage (stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
